These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 38416176)

  • 1. Prostatic Artery Embolization in Patients with Advanced Prostate Cancer: A Prospective Single Center Pilot Study.
    Burkhardt O; Abt D; Hechelhammer L; Kim O; Omlin A; Schmid HP; Engeler D; Zumstein V; Müllhaupt G
    Cardiovasc Intervent Radiol; 2024 Jun; 47(6):771-782. PubMed ID: 38416176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostatic Artery Embolization Using 100-300-μm Trisacryl Gelatin Microspheres to Treat Lower Urinary Tract Symptoms Attributable to Benign Prostatic Hyperplasia: A Single-Center Outcomes Analysis with Medium-Term Follow-up.
    Ayyagari R; Powell T; Staib L; Chapiro J; Raja A; Bhatia S; Chai T; Schoenberger S; Devito R
    J Vasc Interv Radiol; 2020 Jan; 31(1):99-107. PubMed ID: 31771896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The value of contrast-enhanced ultrasonography in detection of prostatic infarction after prostatic artery embolization for the treatment of symptomatic benign prostatic hyperplasia.
    Moschouris H; Stamatiou K; Malagari K; Marmaridou K; Kladis-Kalentzis K; Kiltenis M; Papadogeorgopoulos N; Tsavari A; Manoloudaki K
    Diagn Interv Radiol; 2019 Mar; 25(2):134-143. PubMed ID: 30860077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostatic Artery Embolization in the Treatment of Localized Prostate Cancer: A Bicentric Prospective Proof-of-Concept Study of 12 Patients.
    Mordasini L; Hechelhammer L; Diener PA; Diebold J; Mattei A; Engeler D; Müllhaupt G; Kim SK; Schmid HP; Abt D
    J Vasc Interv Radiol; 2018 May; 29(5):589-597. PubMed ID: 29580712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostatic Artery Embolization (PAE) Using Polyethylene Glycol Microspheres: Safety and Efficacy in 81 Patients.
    Insausti I; Galbete A; Lucas-Cava V; de Ocáriz AS; Solchaga S; Monreal R; de la Cuesta AM; Alfaro R; Sun F; Montesino M; Urtasun F; Bilbao Jaureguízar JI
    Cardiovasc Intervent Radiol; 2022 Sep; 45(9):1339-1348. PubMed ID: 35655035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostatic arterial embolization for the treatment of lower urinary tract symptoms caused by benign prostatic hyperplasia: a comparative study of medium- and large-volume prostates.
    Wang M; Guo L; Duan F; Yuan K; Zhang G; Li K; Yan J; Wang Y; Kang H
    BJU Int; 2016 Jan; 117(1):155-64. PubMed ID: 25851432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Clinical Outcomes of Prostatic Artery Embolization with 50-μm Plus 100-μm Polyvinyl Alcohol (PVA) Particles versus 100-μm PVA Particles Alone: A Prospective Randomized Trial.
    Wang MQ; Zhang JL; Xin HN; Yuan K; Yan J; Wang Y; Zhang GD; Fu JX
    J Vasc Interv Radiol; 2018 Dec; 29(12):1694-1702. PubMed ID: 30297313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate artery embolization has long term efficacy for treatment of severe lower urinary tract symptoms from giant prostatic hyperplasia.
    Somwaru AS; Metting S; Flisnik LM; Nellamattathil MG; Sharma A; Katabathina VS
    BMC Urol; 2020 Oct; 20(1):153. PubMed ID: 33032577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Prostatic Artery Embolization on the Dynamic Component of Benign Prostate Hyperplasia as Assessed by Ultrasound Elastography: A Pilot Series.
    de Assis AM; Moreira AM; Carnevale FC; Marcelino ASZ; de Oliveira Cerri LM; Antunes AA; Srougi M; Cerri GG
    Cardiovasc Intervent Radiol; 2019 Jul; 42(7):1001-1007. PubMed ID: 30993369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative Study Using 100-300 Versus 300-500 μm Microspheres for Symptomatic Patients Due to Enlarged-BPH Prostates.
    Gonçalves OM; Carnevale FC; Moreira AM; Antunes AA; Rodrigues VC; Srougi M
    Cardiovasc Intervent Radiol; 2016 Oct; 39(10):1372-8. PubMed ID: 27509889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostatic Artery Embolization with 250-μm Spherical Polyzene-Coated Hydrogel Microspheres for Lower Urinary Tract Symptoms with Follow-up MR Imaging.
    Franiel T; Aschenbach R; Trupp S; Lehmann T; von Rundstedt FC; Grimm MO; Teichgräber U
    J Vasc Interv Radiol; 2018 Aug; 29(8):1127-1137. PubMed ID: 29910163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostatic Artery Embolization Using Polyethylene Glycol Microspheres: A 1-Year Follow-up Prospective Study Including 30 Patients.
    Pilan BF; de Assis AM; Moreira AM; Rodrigues VCP; Rocha ADD; Carnevale FC
    J Vasc Interv Radiol; 2023 Dec; 34(12):2197-2202. PubMed ID: 37657501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate Artery Embolization for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: Results From a Prospective FDA-Approved Investigational Device Exemption Study.
    Salem R; Hairston J; Hohlastos E; Riaz A; Kallini J; Gabr A; Ali R; Jenkins K; Karp J; Desai K; Thornburg B; Casalino D; Miller F; Hofer M; Hamoui N; Mouli S
    Urology; 2018 Oct; 120():205-210. PubMed ID: 30036614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostatic Artery Embolization in Nonindex Benign Prostatic Hyperplasia Patients: Single-center Outcomes for Urinary Retention and Gross Prostatic Hematuria.
    Ayyagari R; Powell T; Staib L; Chapiro J; Perez-Lozada JC; Bhatia S; Chai T; Schoenberger S; Devito R
    Urology; 2020 Feb; 136():212-217. PubMed ID: 31734349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The STREAM Trial (Prostatic Artery Embolization for the Treatment of Benign Prostatic Hyperplasia) 24-Month Clinical and Radiological Outcomes.
    Tapping CR; Little MW; Macdonald A; Mackinnon T; Kearns D; Macpherson R; Crew J; Boardman P
    Cardiovasc Intervent Radiol; 2021 Mar; 44(3):436-442. PubMed ID: 33210152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical, laboratorial, and urodynamic findings of prostatic artery embolization for the treatment of urinary retention related to benign prostatic hyperplasia. A prospective single-center pilot study.
    Antunes AA; Carnevale FC; da Motta Leal Filho JM; Yoshinaga EM; Cerri LM; Baroni RH; Marcelino AS; Cerri GG; Srougi M
    Cardiovasc Intervent Radiol; 2013 Aug; 36(4):978-86. PubMed ID: 23580116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostatic Artery Embolization as a Treatment Option for Symptomatic Benign Prostatic Hyperplasia: Results from the Prospective Follow-Up Study in Lithuania.
    Jankauskas T; Buržinskis E; Kaupas RS; Basevičius A; Jievaltas M
    Medicina (Kaunas); 2023 Oct; 59(10):. PubMed ID: 37893589
    [No Abstract]   [Full Text] [Related]  

  • 18. Prostatic artery embolization in treating benign prostatic hyperplasia: a systematic review.
    Teoh JY; Chiu PK; Yee CH; Wong HM; Chan CK; Chan ES; Hou SS; Ng CF
    Int Urol Nephrol; 2017 Feb; 49(2):197-203. PubMed ID: 27896579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostatic artery embolization for prostate volume greater than 80 cm3: results from a single-center prospective study.
    Kurbatov D; Russo GI; Lepetukhin A; Dubsky S; Sitkin I; Morgia G; Rozhivanov R; Cimino S; Sansalone S
    Urology; 2014 Aug; 84(2):400-4. PubMed ID: 24929948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intra-vesical Prostatic Protrusion (IPP) Can Be Reduced by Prostatic Artery Embolization.
    Lin YT; Amouyal G; Thiounn N; Pellerin O; Pereira H; Del Giudice C; Déan C; Sapoval M
    Cardiovasc Intervent Radiol; 2016 May; 39(5):690-695. PubMed ID: 26542027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.